SCHEMBL112973

SCHEMBL112973

Cc1cc(C)n(CC(=O)N2CCN(c3ccccc3C(=O)Nc3nc4c(s3)CCCC4)CC2)n1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CXCR3 P49682 2/20 0.53
KCNH2 Q12809 1/20 0.53
MAPT P10636 7/20 0.48
TP53 P04637 3/20 0.48
SLC27A1 Q6PCB7 3/20 0.46
ALDH1A1 P00352 6/20 0.46
KDM4E B2RXH2 2/20 0.44
HPGD P15428 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
LMNA P02545 6/20 0.43
THRB P10828 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
SMN1; SMN2 Q16637 5/20 0.43
GAA P10253 2/20 0.43
KMT2A Q03164 1/20 0.43
NPC1 O15118 2/20 0.42
PKM P14618 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113651 0.91 CXCR3 (0.51) CXCR3KCNH2MAPTALDH1A1KDM4E
SCHEMBL109940 0.89 CXCR3 (0.50) CXCR3KCNH2MAPTTP53ALDH1A1
SCHEMBL112669 0.84 CXCR3 (0.55) CXCR3KCNH2MAPTTP53ALDH1A1
SCHEMBL113280 0.84 CXCR3 (0.54) CXCR3KCNH2MAPTTP53ALDH1A1
SCHEMBL111883 0.83 CXCR3 (0.58) CXCR3KCNH2MAPTTP53ALDH1A1
SCHEMBL111828 0.82 CXCR3 (0.57) CXCR3KCNH2MAPTALDH1A1KDM4E
SCHEMBL113279 0.81 CXCR3 (0.51) CXCR3KCNH2MAPTTP53ALDH1A1
SCHEMBL110697 0.81 CXCR3 (0.51) CXCR3KCNH2MAPTTP53ALDH1A1
SCHEMBL111889 0.81 CXCR3 (0.67) CXCR3KCNH2MAPTALDH1A1CYP1A2
SCHEMBL112182 0.81 CXCR3 (0.57) CXCR3KCNH2ALDH1A1KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2424858-B1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2014-05-14 EP disclosed
EP-2424858-B1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INT (DE) 2014-05-14 EP disclosed
US-8362249-B2 CXCR3 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-29 US disclosed
US-8362249-B2 CXCR3 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-29 US disclosed
US-8362249-B2 CXCR3 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-01-29 US disclosed
EP-2424858-A1 CXCR3 RECEPTOR ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-03-07 EP disclosed
WO-2010126851-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed
WO-2010126851-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 WO disclosed
US-20100273781-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-28 US disclosed
US-20100273781-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-28 US disclosed
US-20100273781-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100273781-A1 CXCR3 RECEPTOR ANTAGONISTS CXCR3, CXCR1, CXCR2 CXCR3 1/4885KCNH2 1384/4885MAPT 4772/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.